GRF6019

· Alkahest, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GRF6019, covering 2020-11-05 to 2021-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease [Phase 2]